載入...
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions
We previously established that COX-2 overexpression promotes breast cancer progression and metastasis. As long-term use of COX-2 inhibitors (COX-2i) can promote thrombo-embolic events, we tested an alternative target, prostaglandin E2 receptor EP4 subtype (EP4), downstream of COX-2. Here we used the...
Na minha lista:
| 發表在: | Cancer Sci |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BlackWell Publishing Ltd
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4462388/ https://ncbi.nlm.nih.gov/pubmed/24981602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12475 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|